Biodesix, Inc.
BDSX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $198 | $151 | $97 | $145 |
| - Cash | $26 | $26 | $43 | $33 |
| + Debt | $62 | $61 | $32 | $10 |
| Enterprise Value | $234 | $185 | $86 | $122 |
| Revenue | $71 | $49 | $38 | $55 |
| % Growth | 45.3% | 28.5% | -29.9% | – |
| Gross Profit | $56 | $36 | $24 | $24 |
| % Margin | 78.2% | 73.5% | 63% | 44% |
| EBITDA | -$29 | -$37 | -$52 | -$35 |
| % Margin | -41% | -75.6% | -134.9% | -65.1% |
| Net Income | -$43 | -$52 | -$65 | -$43 |
| % Margin | -60.2% | -106.2% | -171.3% | -79.2% |
| EPS Diluted | -6.6 | -12.8 | -31 | -31.6 |
| % Growth | 48.4% | 58.7% | 1.9% | – |
| Operating Cash Flow | -$49 | -$23 | -$45 | -$28 |
| Capital Expenditures | -$3 | -$23 | -$4 | -$3 |
| Free Cash Flow | -$52 | -$46 | -$49 | -$31 |